1. Department of Medical Oncology, Beijing Key Laboratory of Clinical Study on Anticancer Molecular Targeted Drugs, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China;
2. Nanjing Jinling Hospital, Nanjing, China;
3. First Hospital of Jilin University, Changchun, China;
4. Nanfang Hospital, Southern Medical University, Guangzhou, China;
5. West China Hospital of Sichuan University, Chendu, China;
6. Chongqing Traditional Chinese Medicine Hospital, Chongqing, China;
7. Medical Oncology, Jinan Central Hospital, Jinan, China;
8. Chifeng Municipal Hospital, Chifeng, China;
9. Anhui Provincial Hospital, Hefei, China;
10. The First People's Hospital of Foshan, Foshan, China;
11. The First Affiliated Hospital of Nanjing Medical University, Nanjing, China;
12. Yunnan Provincial Hospital of Traditional Chinese Medicine, Yunnan, China;
13. Cancer Hospital, Fudan University, Shanghai, China;
14. First Affiliated Hospital of Anhui Medical University, Hefei, China;
15. Beijing Shenogen Pharma, Beijing, China;
16. RG Pharma, Changsha, China;
17. Beijing Shenogen Pharma, Beijing, MA, China;